Under this definition, the AT(N) classification system recognizes three general groups of biomarkers for AD: biomarkers of β‐amyloid plaques (A), fibrillar tau (T), and neurodegeneration or neuronal injury (N).6 Here, MAPT is linked to Alzheimer disease.